Vol 45, No 1 (2014)
Kazuistyka / Case reports
Published online: 2014-01-01
Long-term lenalidomide monotherapy of relapsed multiple myeloma – a case report
DOI: 10.1016/j.achaem.2013.12.002
Acta Haematol Pol 2014;45(1):89-92.
Abstract
Multiple myeloma (MM) is a malignant and still incurable proliferative disease of the hematopoietic system. Introduction to therapy over a decade ago new therapeutic strategies, including immunomodulatory drugs (IMiDs) significantly improved the prognosis in this type of cancer. Despite high response rate multiple myeloma is characterized by a relapsing course in most patients and becomes more resistance to treatment. The article presents the case of a 49-year-old patient with relapsed multiple myeloma treated with lenalidomide monotherapy for 36 months.
Keywords: Multiple myelomaImmunomodulatory drugsLenalidomide
